Wayne, PA – According to filings with the U.S. Securities and Exchange Commission, PurpleLab is raising $40,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Mark Brosso played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About PurpleLab
PurpleLab is a healthtech company focused on driving decisive action based on precise insights from real-world data. The company’s sophisticated HIPAA-compliant analytics platform, proven domain expertise and wealth of transactional and novel RWD, empowers healthcare stakeholders with the real-world evidence they need to solve conventional, new, and emerging challenges. With PurpleLab clients can derive value faster, more cost effectively, and with significantly greater confidence. Our highly experienced experts conform billions of raw claims and clinical healthcare transactions using our proprietary platform, HealthNexus. We semantically harmonize critical events and relationships between data types at scale, making them analytics-ready. With integrated insights on de-identified patients, providers and payers clients receive ongoing objective, quantitative, predictive, and ad hoc real-world evidence to meet their business objectives. These include diagnosis, medications, procedures, measurements, observations and indications. PurpleLab continues to grow its data warehouse with trusted data partners across the healthcare ecosystem.

To learn more about PurpleLab, visit http://www.purplelab.com/

Contact:
Mark Brosso, Chief Executive Officer
484-263-9982
https://www.linkedin.com/in/mark-brosso-73861b5/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved